TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Dr. Ralph Defronzo
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025

Dr. Ralph DeFronzo presented insights on icovamenib, a potential disease-modifying therapy for diabetes, highlighting its ability to restore beta cell mass and function through menin inhibition during the 23rd World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease.

Insights
BMEA   positive

Company is presenting promising clinical research on a novel diabetes treatment approach with potential to address significant unmet medical needs in diabetes care